Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/Hartford
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Hartford, CT

Studies commonly pay $75 to $4,500 per completed study

447 clinical trials are currently recruiting participants within 30 miles of Hartford. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

447studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Hartford right now

Top 25 of 447 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Smilow Cancer Hospital at Saint Francis — Hartford, Connecticut (0.2 mi) · Sponsor: Abramson Cancer Center at Penn Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06551116)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
DaVita Clinical Research — Middlebury, Connecticut (28.2 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Colitis Ulcerative Phase 2 Interventional 204 participants sought
Bristol Hospital- Site Number : 8400017 — Bristol, Connecticut (15.2 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06867094)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia

Hemiplegia, Cerebral Palsy N/A Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (22.5 mi) · Sponsor: University of Connecticut
See eligibility & contact on ClinicalTrials.gov (NCT06579027)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Waterbury, Connecticut (23.8 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a) Phase 3 Interventional 5,700 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07517263)

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Non-small Cell Lung Cancer Phase 1, Phase 2 Interventional 36 participants sought
Smilow Cancer Hospital - Hamden Care Center — Hamden, Connecticut (27.9 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT04210492)

Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure

Heart Failure N/A Interventional 1,200 participants sought
Baystate Medical Center — Springfield, Massachusetts (23.7 mi) · Sponsor: Analog Device, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05650541)

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Advanced Solid Tumors Phase 1 Interventional 798 participants sought
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut — Plainville, Connecticut (11.0 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05719558)

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA) Phase 3 Interventional 400 participants sought
Chase Medical Research LLC — Waterbury, Connecticut (23.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07481630)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
University of Connecticut Health Center ( Site 0128) — Farmington, Connecticut (8.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Phase 2 Interventional 310 participants sought
Site 0158 - Hartford HealthCare — Hartford, Connecticut (0.2 mi) · Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See eligibility & contact on ClinicalTrials.gov (NCT05128825)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Middlesex Hospital — Middletown, Connecticut (14.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 143 participants sought
Medical Research Center of Connecticut, LLC — Hamden, Connecticut (27.9 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06598943)
Actively enrolling

Studies you may be able to join near Hartford

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Hartford

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Trials

100 Retreat Ave, Hartford, CT 06106
(860) 244-0148

Olin Neuropsychiatry Research Center - Institute of Living

200 Retreat Ave, Hartford, CT 06102
(860) 545-7000

Root Center for Advanced Recovery - Henderson/Johnson Clinic

★ 3.6 (29 reviews)
16-18 Weston St, Hartford, CT 06120
(860) 527-5100
"Everyone was SO nice and helpful and concerned about my individual needs.<br>Quest team found a vein right away! They give you a snack and juice and…"
— Meg Carey, 5★

Institute of Living- Olin Neuropsychiatry Research Center

400 Washington St, Hartford, CT 06106
(860) 545-7800

Hartford Hospital ERD/ERC Building

★ 4.4
415004001, Hartford, CT 06106
(860) 972-4444
"Good experience, staff is very cordial"
— Delphia White, 5★

Center Building - Institute of Living

★ 2.1 (41 reviews)
200 Retreat Ave, Hartford, CT 06102
(860) 545-7000
"Giving a single star only.<br><br>For the few nurses and staff inside the inpatient ward who are compassionate, they deserve a raise but they are ind…"
— Melted Pennies, 1★

CT Clinical Research

160 West St Ste 1A, Cromwell, CT 06416
(860) 632-0144

Institute of Living- Anxiety Disorders Center

★ 3.0 (8 reviews)
200 Retreat Ave, Hartford, CT 06106
(860) 545-7685
"Maria is fantastic. She's helped my daughter on her healing journey from anxiety & OCD. My daughter is doing things she couldn't do a year ago!!!<br>…"
— Krystal Fox, 5★

The Center for Internet and Technology Addiction

★ 3.5
8 Lowell Rd, West Hartford, CT 06119
(860) 561-8727 ext. 4
"Very knowledgeable organization. They helped my family so much!"
— Isabella Beltran, 5★

Clinical trials in Hartford: what's recruiting

The Hartford area currently has 447 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Hartford, the most active research areas are:

  • Cancer & Oncology13 studies
  • Immune & Skin3 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Hartford, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Hartford

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Hartford participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Hartford pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Hartford?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
What is the difference between a research center and a hospital study in Hartford?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Hartford?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Hartford.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Hartford typically complete one or two studies per year.

Paid clinical trials near Hartford

Other metros within reach

Springfield, MA325 Waterbury, CT1,145 New Haven, CT1,181 Norwich, CT122 Bridgeport, CT1,454 Danbury, CT1,159 Worcester, MA269 Poughkeepsie, NY75

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Hartford Bladder Issues Due To Spinal Cord Injury in Hartford All conditions

More of CT

Bridgeport1,454 New Haven1,181 Danbury1,159 Waterbury1,145 Norwich122

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts